Global Ganja Report

FDA commissioner Scott Gottlieb has suddenly announced that he is stepping down, leaving lots of unfinished business—including the status of CBD under the agency's regs. Biotech stocks are taking a tumble on the news, while tobacco is bullish and cannabis is mixed.

As demands mount for expungement of cannabis convictions in the 10 states that have legalized, as well as in Canada, the cumbersome bureaucracy of court systems is an obstacle. Now San Francisco has teamed with a software company to automate the process—a partnership that could serve as a model for other jurisdictions across North America.

A measure to legalize cannabis in the Aloha State died in the legislature. But Hawaii's long-delayed medical marijuana program is finally taking off—and has now been opened to non-residents.

Sacramento is preparing to unleash the National Guard on small illegal growers in the Emerald Triangle just as it is pushing the "Twin Tunnels" project to facilitate water diversions to Central Valley ag-biz—which is increasingly growing cannabis. Small growers face punitive measures for irresponsible practices while big growers stand to gain from official water diversions that may be ultimately far more irresponsible.

A newly released study from the University of New Mexico actually finds more therapeutic benefits to THC than its sexy sibling cannabinoid CBD. However, the study is based on a single cellphone app—which, for better or worse, is certainly unorthodox methodology.

In a sign of progress, the courts are increasingly siding with employees fired for use of cannabis under state medical marijuana programs. The latest such victory comes from Arizona, where precedent has been set. Other states, however, are still awaiting legal clarity on the question.

A former Arizona Walmart employee and card-holding medical marijuana patient who was fired after testing positive for cannabis has won a wrongful termination suit in federal court.

Following the crackdown on CBD-infused foods and beverages by authorities in New York City and elsewhere, Capitol Hill lawmakers are formally calling upon the FDA to provide immediate clarity on the question. Meanwhile, New York, at least is starting to lift the pressure.

After what has been an agonizing delay for many patients, Louisiana's first medical marijuana harvest has just cleared inspection. But there are still more hurdles before the first extracts and tinctures will begin arriving in the state's nine approved pharmacies.